List of Medrio CDMS/EDC Customers
San Francisco, 94104, CA,
United States
Since 2010, our global team of researchers has been studying Medrio CDMS/EDC customers around the world, aggregating massive amounts of data points that form the basis of our forecast assumptions and perhaps the rise and fall of certain vendors and their products on a quarterly basis.
Each quarter our research team identifies companies that have purchased Medrio CDMS/EDC for Clinical Trial Management from public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources, including the customer size, industry, location, implementation status, partner involvement, LOB Key Stakeholders and related IT decision-makers contact details.
Companies using Medrio CDMS/EDC for Clinical Trial Management include: Nevro, a United States based Life Sciences organisation with 1087 employees and revenues of $406.0 million, Clinical Trials Resource Group, a United States based Life Sciences organisation with 25 employees and revenues of $3.0 million, Atlantic Research Group, a United States based Professional Services organisation with 10 employees and revenues of $1.0 million and many others.
Contact us if you need a completed and verified list of companies using Medrio CDMS/EDC, including the breakdown by industry (21 Verticals), Geography (Region, Country, State, City), Company Size (Revenue, Employees, Asset) and related IT Decision Makers, Key Stakeholders, business and technology executives responsible for the software purchases.
The Medrio CDMS/EDC customer wins are being incorporated in our Enterprise Applications Buyer Insight and Technographics Customer Database which has over 100 data fields that detail company usage of software systems and their digital transformation initiatives. Apps Run The World wants to become your No. 1 technographic data source!
Apply Filters For Customers
| Logo | Customer | Industry | Empl. | Revenue | Country | Vendor | Application | Category | When | SI | Insight |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Atlantic Research Group | Professional Services | 10 | $1M | United States | Medrio | Medrio CDMS/EDC | Clinical Trial Management | 2023 | n/a |
In 2023, Atlantic Research Group implemented Medrio CDMS/EDC to support clinical data management and study builds across oncology, neurology and immunology in the United States. The deployment targeted Clinical Trial Management capabilities to centralize electronic data capture, study build workflows and edit check orchestration for a small professional services firm with approximately 10 employees.
Medrio CDMS/EDC was configured to manage case report form construction, automated edit checks, query workflows and database lock processes, supporting clinical operations and data management business functions. Atlantic Research Group reported up to a 50% reduction in edit checks and the ability to achieve database lock within two weeks of resolving final queries, and the organization explored other integrated Medrio modules for example eConsent as part of the deployment.
|
 |
Clinical Trials Resource Group | Life Sciences | 25 | $3M | United States | Medrio | Medrio CDMS/EDC | Clinical Trial Management | 2023 | n/a |
In 2023 Clinical Trials Resource Group implemented Medrio CDMS/EDC together with Medrio RTSM to manage a complex, multi-site ophthalmology trial in the United States. The deployment targeted Clinical Trial Management functions supporting clinical operations, data management, and site monitoring across participating investigational sites.
Medrio CDMS/EDC was configured to provide eCRF design, real-time data capture, query management, and centralized data cleaning workflows, while Medrio RTSM handled randomization and trial supply management for the blinded ophthalmology protocol. The implementation relied on a cloud-oriented EDC architecture with study-level configuration and role-based user access, enabling iterative build cycles and streamlined study configuration.
Governance centered on centralized data cleaning and query resolution processes owned by clinical operations and data management, with site efficiency practices to accelerate database readiness and lock activities. Per the Medrio case study, CTRG achieved faster build times approximately 38% faster, 90% real-time data cleaning, and improved site efficiency that reduced database lock timelines, illustrating measurable operational outcomes from the Clinical Trial Management deployment using Medrio CDMS/EDC.
|
 |
Nevro | Life Sciences | 1087 | $406M | United States | Medrio | Medrio CDMS/EDC | Clinical Trial Management | 2023 | n/a |
In 2023, Nevro deployed Medrio CDMS/EDC, leveraging Medrio ePRO and EDC, to capture patient-reported outcomes previously collected on paper for its Senza SCS clinical program in the United States. The deployment targeted Clinical Trial Management workflows for device trials, aligning electronic patient-reported outcome capture and clinical data capture within a single Medrio CDMS/EDC environment.
The implementation configured Medrio ePRO for direct patient entry and Medrio EDC for site data capture, reducing reliance on paper source documents and consolidating case report form workflows. Configuration work emphasized ePRO scheduling, visit-based CRF mapping, and electronic source auditability, consistent with Clinical Trial Management functional practices for device studies.
Operational coverage included multiple clinical studies on the Medrio platform, with Medrio reporting 25 studies implemented and 10 active at the time of the customer story, all within Nevro’s Senza SCS program in the United States. The rollout focused on site usability improvements, enabling sites to capture structured PRO and clinical data within the Medrio CDMS/EDC instance, and supporting safety and analysis data flows.
Governance and monitoring shifted toward centralized electronic source management and reduced on-site verification, with Nevro eliminating two thirds of source data verification according to the published account. The move yielded faster access to cleaned data for safety review and downstream analysis as reported, and the implementation emphasized electronic audit trails and role-based access for Clinical Trial Management oversight.
|
Buyer Intent: Companies Evaluating Medrio CDMS/EDC
Discover Software Buyers actively Evaluating Enterprise Applications
| Logo | Company | Industry | Employees | Revenue | Country | Evaluated | ||
|---|---|---|---|---|---|---|---|---|
| No data found | ||||||||